Shuibing Chen is a Professor at Weill Cornell Medical College specializing in Chemical Biology and Surgery. His research focuses on the intersection of biochemistry and biophysics, exploring novel approaches to diabetes treatment and cancer biology. With over two decades of experience in stem cell research, he has significantly contributed to understanding the mechanisms underlying pancreatic beta cell function and differentiation. His work leverages human pluripotent stem cells (hPSCs) to model diseases and identify new therapeutic targets, particularly in diabetes and cancer. He has authored numerous influential publications documenting breakthroughs in his field, including studies on SARS-CoV-2, and has received various grants to further his research initiatives. He is recognized for his innovative contributions to the development of organoid technology for studying disease mechanisms and drug discovery. His academic journey also includes a commitment to mentoring young scientists, fostering a collaborative research environment.
Weill Cornell Medical College • New York, NY
Leading research and teaching in Chemical Biology and Surgery.